If you’re one of the millions of people taking medication for high blood pressure, this is news you can’t afford to ignore. A massive 17-year study from Columbia University has uncovered significant risks associated with a widely prescribed drug, suggesting that a common alternative might be a much safer choice for many.
The groundbreaking research, which followed over 730,000 patients, compared two common blood pressure medications: chlorthalidone and hydrochlorothiazide. While both are effective at lowering blood pressure, the study found that chlorthalidone comes with a higher risk of serious side effects, potentially leading to dangerous health complications. This new evidence could change how doctors approach high blood pressure treatment.
Key Takeaways
A major new study found that the blood pressure drug chlorthalidone is linked to a significantly higher risk of dangerously low potassium levels.
Patients taking chlorthalidone were more than three times as likely to develop this condition compared to those taking a similar drug, hydrochlorothiazide.
Low potassium can lead to serious health issues, including irregular heartbeats, kidney problems, and an increased risk of type 2 diabetes.
If you take chlorthalidone, experts suggest talking to your doctor about monitoring your potassium levels or potentially switching to a safer alternative.
A Tale of Two Drugs
For years, both chlorthalidone and hydrochlorothiazide have been go-to treatments for high blood pressure. However, this new study, published in JAMA Internal Medicine, reveals a critical difference between them. Researchers discovered that 6.3% of patients taking chlorthalidone developed hypokalemia, the medical term for low potassium. In stark contrast, only 1.9% of those on hydrochlorothiazide faced the same issue. This means you could be over three times more likely to experience this side effect if you’re taking chlorthalidone.
0 Comments:
Post a Comment